Centessa Pharmaceuticals to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
Centessa Pharmaceuticals (Nasdaq: CNTA), a clinical-stage pharmaceutical company, has announced its participation in the Morgan Stanley 22nd Annual Global Healthcare Conference in New York, NY. The company's management team is scheduled for a fireside chat on Wednesday, September 4th at 1:05 PM ET.
Investors and interested parties can access a live audio webcast of the event, as well as an archived recording, through the "Events and Publications" tab on the investor relations section of Centessa's website at https://investors.centessa.com/events-presentations. This participation provides an opportunity for Centessa to showcase its progress in discovering and developing transformational medicines for patients.
Centessa Pharmaceuticals (Nasdaq: CNTA), una società farmaceutica in fase clinica, ha annunciato la sua partecipazione alla 22ª Conferenza Globale Annuale sulla Sanità di Morgan Stanley a New York, NY. Il team di gestione dell'azienda è programmato per un'intervista informale mercoledì 4 settembre alle 13:05 ET.
Gli investitori e le parti interessate possono accedere a un webcast audio dal vivo dell'evento, oltre a una registrazione archiviata, tramite la scheda
Centessa Pharmaceuticals (Nasdaq: CNTA), una empresa farmacéutica en etapa clínica, ha anunciado su participación en la 22ª Conferencia Global Anual de Salud de Morgan Stanley en Nueva York, NY. El equipo directivo de la compañía está programado para una conversación informal el miércoles 4 de septiembre a la 1:05 PM ET.
Los inversores y partes interesadas pueden acceder a un webcast de audio en vivo del evento, así como a una grabación archivada, a través de la pestaña de
Centessa Pharmaceuticals (Nasdaq: CNTA), 임상 단계의 제약 회사가 모건 스탠리 제22회 글로벌 헬스케어 컨퍼런스에 뉴욕, NY에서 참석한다고 발표했습니다. 회사 경영진은 9월 4일 수요일 오후 1시 5분 ET에 파이어사이드 채팅을 진행할 예정입니다.
투자자와 관심 있는 관계자는 실시간 오디오 웹캐스트를 통해 이벤트에 접근할 수 있으며, archived 녹음도 이용할 수 있습니다. Centessa 웹사이트의 투자자 관계 섹션에 있는
Centessa Pharmaceuticals (Nasdaq: CNTA), une entreprise pharmaceutique en phase clinique, a annoncé sa participation à la 22ème Conférence Annuelle Mondiale sur la Santé de Morgan Stanley à New York, NY. L'équipe de direction de l'entreprise est prévue pour un entretien informel mercredi 4 septembre à 13h05 ET.
Les investisseurs et les parties intéressées peuvent accéder à un webcast audio en direct de l'événement, ainsi qu'à un enregistrement archivé, via l'onglet
Centessa Pharmaceuticals (Nasdaq: CNTA), ein Pharmaunternehmen in der klinischen Phase, hat seine Teilnahme an der 22. jährlichen globalen Gesundheitskonferenz von Morgan Stanley in New York, NY, bekannt gegeben. Das Management-Team des Unternehmens wird am Mittwoch, den 4. September um 13:05 Uhr ET an einem Kaminabend teilnehmen.
Investoren und Interessierte können über den Tab live-audio-webcast auf die Veranstaltung zugreifen sowie eine archivierte Aufnahme über die Rubrik
- None.
- None.
BOSTON and LONDON, Aug. 21, 2024 (GLOBE NEWSWIRE) -- Centessa Pharmaceuticals plc (Nasdaq: CNTA), a clinical-stage pharmaceutical company that aims to discover and develop transformational medicines for patients, today announced that members of its management team will participate in the Morgan Stanley 22nd Annual Global Healthcare Conference in New York, NY. A fireside chat is scheduled for Wednesday, September 4th at 1:05 PM ET.
The live audio webcast of this event, as well as an archived recording, will be available under the “Events and Publications” tab on the investor relations section of the Centessa Pharmaceuticals website at https://investors.centessa.com/events-presentations.
About Centessa Pharmaceuticals
Centessa Pharmaceuticals plc is a clinical-stage pharmaceutical company that aims to discover and develop transformational medicines for patients. Our most advanced programs include a hemophilia program, an orexin agonist program for the treatment of narcolepsy and other sleep-wake disorders and an immuno-oncology program focused on our LockBody technology platform. We operate with the conviction that each one of our programs has the potential to change the current treatment paradigm and establish a new standard of care. For more information, visit www.centessa.com, which does not form part of this release.
Contact:
Kristen K. Sheppard, Esq.
SVP of Investor Relations
investors@centessa.com
FAQ
When is Centessa Pharmaceuticals (CNTA) participating in the Morgan Stanley Healthcare Conference?
How can investors access Centessa Pharmaceuticals' (CNTA) presentation at the Morgan Stanley conference?
What type of company is Centessa Pharmaceuticals (CNTA)?
Where is the Morgan Stanley 22nd Annual Global Healthcare Conference being held?
